Skip to main content

Aptose Bioscns(APTO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low0.8200
Day High0.8500
Open:0.8200
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest News

CORRECTION -- Aptose Presents Highlights from Corporate Update and KOL Event
Globe Newswire - Thu Jun 2, 7:10PM CDT
Globe Newswire
Thu Jun 2, 7:10PM CDT
HM43239 Delivers New Complete Remission at 160mg Dose in AML with Wildtype FLT3 New “G3” Formulation of Luxeptinib Demonstrates Encouraging PK Results ...
Aptose Presents Highlights from Corporate Update and KOL Event
Globe Newswire - Thu Jun 2, 4:30PM CDT
Globe Newswire
Thu Jun 2, 4:30PM CDT
HM43239 Delivers New Complete Remission at 160mg Dose in AML with Wildtype FLT3 New “G3” Formulation of Luxeptinib Demonstrates Encouraging PK Results ...
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
Globe Newswire - Tue May 31, 3:15PM CDT
Globe Newswire
Tue May 31, 3:15PM CDT
SAN DIEGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...

Latest Articles